Healthcare >> CEO Interviews >> November 26, 2007

John K. Stroh – Neomatrix, Llc

TWST: May we start with a short overview of NeoMatrix?

Mr. Stroh: NeoMatrix has developed the HALO breast Pap test, which is an early

screen for breast cancer risk. HALO collects nipple